Monoclonal antibody production and purification.
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201400281P
- Awardee
-
Epitomics Inc. UEI GHX3CZALWZT9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,455
Award facts
- Contract value 100% obligated
- $6,455.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Hillsborough, CA 94010, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$57 | |
| Original award | $6,512 |
About this award
The National Cancer Institute awarded a purchase order to Epitomics Inc. for monoclonal antibody production and purification on May 8, 2014, with a ceiling value of $6,455.20. Work is performed in Hillsborough, California. The order is firm fixed price with an ultimate completion date of August 5, 2014.
Quick answers
Who was awarded contract HHSN261201400281P?
HHSN261201400281P was awarded to Epitomics Inc. by National Cancer Institute (National Institutes of Health) on May 8, 2014.
How much is contract HHSN261201400281P worth?
The government has obligated $6,455 on HHSN261201400281P.
Was contract HHSN261201400281P competed?
The extent of competition for HHSN261201400281P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award